TY - JOUR
T1 - Frontotemporal dementia with amyotrophic lateral sclerosis
T2 - a clinical comparison of patients with and without repeat expansions in C9orf72.
AU - Snowden, Julie S
AU - Harris, Jennifer
AU - Richardson, Anna
AU - Rollinson, Sara
AU - Thompson, Jennifer C
AU - Neary, David
AU - Mann, David M A
AU - Pickering-Brown, Stuart
N1 - 089701, Wellcome Trust, United KingdomG0701441, Medical Research Council, United Kingdom, Medical Research Council, United Kingdom, Wellcome Trust, United Kingdom
PY - 2013
Y1 - 2013
N2 - Repeat expansions in C9orf72 are a major cause of frontotemporal dementia with amyotrophic lateral sclerosis (FTD-ALS). Not all FTD-ALS patients show expansions. The study examined whether there are clinical differences between FTD-ALS patients with and without expansions in C9orf72. We examined case notes from consecutive FTD-ALS patients, screened for C9orf72 expansions, and documented demographic, neurological, behavioural and cognitive characteristics. Sixty patients met the selection criteria, of whom 11 showed expanded repeats (C9-positive) and 49 did not (C9-negative). A strong male bias was present in the C9-negative group only. A family history of FTD or ALS was recorded in both groups, but was significantly more common in C9-positive cases. Psychotic and irrational behaviours, apathy, disinhibition and loss of empathy were significantly more common in C9-positive cases, with a trend towards more frequent bulbar signs. No differences were found in onset age, presentation (ALS or FTD first), or cognitive changes (language and executive impairments). In conclusion, FTD-ALS is not clinically uniform. Phenotypic differences exist between patients with and without C9orf72 expansions, suggesting that FTD-ALS may be underpinned by distinct neurobiological substrates. The presence of psychiatric symptoms in the context of FTD-ALS should alert clinicians to the possibility of C9orf72 expansions.
AB - Repeat expansions in C9orf72 are a major cause of frontotemporal dementia with amyotrophic lateral sclerosis (FTD-ALS). Not all FTD-ALS patients show expansions. The study examined whether there are clinical differences between FTD-ALS patients with and without expansions in C9orf72. We examined case notes from consecutive FTD-ALS patients, screened for C9orf72 expansions, and documented demographic, neurological, behavioural and cognitive characteristics. Sixty patients met the selection criteria, of whom 11 showed expanded repeats (C9-positive) and 49 did not (C9-negative). A strong male bias was present in the C9-negative group only. A family history of FTD or ALS was recorded in both groups, but was significantly more common in C9-positive cases. Psychotic and irrational behaviours, apathy, disinhibition and loss of empathy were significantly more common in C9-positive cases, with a trend towards more frequent bulbar signs. No differences were found in onset age, presentation (ALS or FTD first), or cognitive changes (language and executive impairments). In conclusion, FTD-ALS is not clinically uniform. Phenotypic differences exist between patients with and without C9orf72 expansions, suggesting that FTD-ALS may be underpinned by distinct neurobiological substrates. The presence of psychiatric symptoms in the context of FTD-ALS should alert clinicians to the possibility of C9orf72 expansions.
KW - Aged
KW - Amyotrophic Lateral Sclerosis/diagnosis/epidemiology/genetics
KW - Cohort Studies
KW - DNA Repeat Expansion/genetics
KW - Female
KW - Frontotemporal Dementia/diagnosis/epidemiology/genetics
KW - Genetic Testing/methods
KW - Humans
KW - Male
KW - Middle Aged
KW - Proteins/genetics
U2 - 10.3109/21678421.2013.765485
DO - 10.3109/21678421.2013.765485
M3 - Article
C2 - 23421625
SN - 2167-9223
VL - 14
SP - 172
EP - 176
JO - Amyotrophic lateral sclerosis & frontotemporal degeneration
JF - Amyotrophic lateral sclerosis & frontotemporal degeneration
IS - 3
ER -